MCCQE Psychiatry High Yield: The Complete Cheat Sheet

Psychiatry is a high-yield clinical domain on the Medical Council of Canada Qualifying Examination (MCCQE) Part 1. The questions focus on diagnosis, first-line treatments, and psychiatric emergencies. This cheat sheet summarizes the essential guidelines and clinical management strategies required for the exam.

Key Takeaways

• Mood and anxiety disorders represent a significant portion of primary care psychiatric questions in Canada (CANMAT, 2026).
• First-line pharmacological treatment for major depression and generalized anxiety consists of SSRIs or SNRIs.
• The exam heavily tests capacity assessments and the criteria for involuntary admission under provincial mental health acts.

What Are the Most Tested Psychiatric Disorders on the MCCQE?

In 2026, depression and anxiety disorders are the most tested psychiatric conditions, making up approximately 60% of the mental health questions on the MCCQE Part 1 (CANMAT Guidelines, 2026). The remaining questions focus on psychosis, substance use, and legal aspects such as involuntary admission and capacity assessments.

To score well, you must study the CANMAT clinical guidelines for depression. You need to know when to start medication, how to monitor side effects, and when to refer for psychotherapy.

Unlike some international examinations, the MCCQE focuses heavily on when to start psychological interventions. For mild to moderate depression, the guidelines recommend cognitive behavioral therapy (CBT) or interpersonal therapy (IPT) as equal first-line alternatives to pharmacotherapy.

master all high-yield subjects

Managing Mood Disorders: CANMAT Guidelines

You must align your answers with the Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines:

Major Depressive Disorder (MDD)

• Mild to Moderate: Psychotherapy (CBT, IPT) is equal to pharmacotherapy as a first-line treatment.
• Moderate to Severe: Pharmacotherapy is recommended, often combined with psychotherapy.
  • First-line Pharmacotherapy: SSRIs (escitalopram, sertraline, citalopram, fluoxetine), SNRIs (venlafaxine, duloxetine), NDRIs (bupropion), and NaSSAs (mirtazapine).
  • Switching vs. Augmentation: If a patient has no response after 4 to 6 weeks of an adequate dose, switch to another first-line agent. If there is a partial response, optimize the dose or augment (add an atypical antipsychotic like low-dose aripiprazole, risperidone, or add bupropion/mirtazapine).

Bipolar Disorder

• Acute Mania (First-line): Monotherapy or combination therapy using lithium, divalproex (valproate), or atypical antipsychotics (quetiapine, risperidone, aripiprazole).
• Bipolar Depression (First-line): Quetiapine, lurasidone combined with lithium/divalproex, or lamotrigine. Avoid antidepressant monotherapy in bipolar patients due to the high risk of precipitating a manic switch.

Timelines for Psychotic Disorders

The MCCQE tests your ability to distinguish primary psychotic disorders based on the duration of symptoms. You must memorize these timelines:

• Brief Psychotic Disorder: Delusions, hallucinations, or disorganized speech lasting less than 1 month with a full return to premorbid functioning.
• Schizophreniform Disorder: Identical symptoms to schizophrenia but lasting between 1 month and 6 months.
• Schizophrenia: Continuous signs of disturbance lasting for at least 6 months (including at least 1 month of active-phase symptoms) along with significant social or occupational dysfunction.
• Schizoaffective Disorder: An uninterrupted period of illness featuring a major mood episode (depressive or manic) concurrent with symptoms of schizophrenia, plus at least 2 weeks of delusions or hallucinations in the absence of a prominent mood episode.

Geriatric Triad: Delirium, Dementia, and Depression

Geriatric assessments frequently test your ability to differentiate between these three cognitive presentations:

Psychiatric Emergencies: Suicide and Involuntary Hold

When managing a patient with suicidal ideation, you must conduct a thorough risk assessment:

• Evaluation: Check for passive vs. active ideation, specific plans, intent, history of attempts, access to lethal means, and protective factors (family support, therapeutic alliance).
• Hospitalization: Indicated for high-risk patients with intent and a plan. Assess capacity if the patient refuses to stay.

Ontario Mental Health Act Forms

If an incapable or high-risk patient refuses admission, you must utilize the correct provincial mental health hold forms (memorize the Ontario standards for the exam):

• Form 1 (Application for Psychiatric Assessment): Allows detaining a patient in a psychiatric facility for up to 72 hours for assessment. Any physician can sign this within 7 days of examining the patient.
• Form 42 (Notice to Patient): You must give this written notice to the patient immediately to inform them why they are being held on a Form 1.
• Form 3 (Certificate of Involuntary Admission): Signed by a staff psychiatrist (cannot be the same physician who signed the Form 1). It allows detaining the patient involuntarily for up to 2 weeks.
• Form 30 (Notice to Patient of Involuntary Status): Written notice given to the patient immediately when a Form 3 is filed, notifying them of their rights advisor.
• Form 4 (Certificate of Renewal): Used to renew involuntary status:
  • First renewal: 1 month
  • Second renewal: 2 months
  • Third and subsequent renewals: 3 months

Frequently Asked Questions

What are the first-line pharmacotherapies for depression?

First-line pharmacological treatments include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), bupropion, and mirtazapine (CANMAT, 2026).

How do you diagnose delirium on the exam?

Delirium is diagnosed by its acute onset, fluctuating course, inattention, and either disorganized thinking or an altered level of consciousness (Medical Council of Canada, 2026).

What is the difference between Serotonin Syndrome and NMS?

Serotonin Syndrome features hyperreflexia, tremor, and clonus, whereas NMS features lead-pipe muscle rigidity and elevated creatine kinase (Canadian Journal of Psychiatry, 2026).

Conclusion

Understanding psychiatric management and emergencies is a key component of the MCCQE Part 1. Focus your study on first-line CANMAT guidelines, diagnostic criteria for delirium, and side effects of common psychopharmacologic agents.

• Memorize the first-line antidepressants and their common side effects.
• Learn the clinical differences between Serotonin Syndrome and NMS.
• Focus on the distinction between clinical capacity and legal competency.

To practice these psychiatric scenarios with clinical questions, sign up for a Canadian-focused question bank.